Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variant

Acta Neuropathologica

Volumn 94, Issue 6, 1997, Pages 539-548

  Thorns, Veronika ^a   Mallory, Margaret ^a   Hansen, Lawrence ^a   Masliah, Eliezer ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein expression; Glutamate receptor; Lewy body variant; Vulnerability

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; BRAIN NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LEWY BODY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODIES; RECEPTORS, METABOTROPIC GLUTAMATE; SEVERITY OF ILLNESS INDEX;

EID: 0030777850     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010050748     Document Type: Article

References (47)

1. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239-259
2. Brion JP, Couck AM, Conreur JL (1995) Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease. Neurodegeneration 4: 13-21
3. Brown TH, Zador AM (1990) Hippocampus. In: Shepherd GM (ed) The synaptic organization of the brain, 3rd edn. Oxford University Press, New York, pp 346-389
4. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA (1996) Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 16: 186-199
5. Choi BH, Kim R, Vaughan PJ, Lau A, Nostrand WE van, Cotman CW, Cunningham DD (1995) Decreases in protease nexins in Alzheimer's disease brain. Neurobiol Aging 16: 557-562
6. Cummings BJ, Cotman CW (1995) Image analysis of betaamyloid load in Alzheimer's disease and relation to dementia severity. Lancet 346: 1524-1528
7. Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, Mattson MP (1996) Increased activity-regulating and neuroprotective efficacy of a secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J Neurochem 67: 1882-1896
8. Gomez-lsla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16: 4491-4500
9. Greenamyre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging 10: 593-602
10. Hansen LA, Crain BJ (1995) Making the diagnosis of mixed and non-Alzheimer's dementia. Arch Pathol Lab Med 119: 1023-1031
11. Hansen LA, Galasko D (1992) Lewy body disease. Curr Opin Neurol Neurosurg 5: 889-894
12. Hansen LA, Masliah E, Quijada-Fawcett S, Rexin D (1991) Entorhinal neurofibrillary tangles in Alzheimer's disease with Lewy bodies. Neurosci Lett 129: 269-272
13. Hansen LA, Masliah E, Galasko D, Terry R (1993) Plaque only Alzheimer's disease is usually the Lewy body variant and vice versa. J Neuropathol Exp Neurol 52: 648-654
14. Harrison PJ, Barton AJL, Procter AW, Bowen DM, Pearson RCA (1994) The effects of Alzheimer's disease, other dementias, and premortem course on β-amyloid precursor protein mRNA in frontal cortex. J Neurochem 62: 635-644
15. Higgins GA, Lewis DA, Bahmanyar S, Goldgaber D, Gajdusek DC, Young WG, Morrison JH, Wilson MC (1988) Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci USA 85: 1297-1301
16. Hyman BT, Hoesen GW van, Kromer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 20: 472-481
17. Hyman BT, Hoesen GW van, Damasio AR (1987) Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 22: 37-40
18. Johnson SA, Pasinetti GM, May PC, Ponte PA, Cordell B, Finch CE (1988) Selective reduction of mRNA for the betaamyloid precursor protein that lacks a Kunitz-type protease inhibitor motif in cortex from Alzheimer's brains. Exp Neurol 102: 264-268
19. Johnson SA, McNeil T, Cordell B, Finch CE (1990) Relation of neuronal APP751/APP695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science 258: 854-857
20. Katzman R, Galasko D, Saitoh T, Thal LJ, Hansen LA (1995) Genetic evidence that the Lewy body variant is indeed a phenotypic variance of Alzheimer's disease. Brain Cogn 28: 259- 265
21. Lahiri DK, Nail C (1995) Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Mol Brain Res 32: 233-240
22. Lee RKK, Wurtman RJ, Cox AJ, Nitsch RM (1995) Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc Natl Acad Sci USA 92: 8083-8087
23. Lee RKK, Jimenez J, Cox AJ, Wurtman RJ (1996) Metabotropic glutamate receptors regulate APP processing in hippocampal neurons and cortical astrocytes derived from fetal rats. Ann NY Acad Sci 777: 338-343
24. Masliah E, Terry RD, DeTeresa RM, Hansen L (1989) Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett 103: 234-239
25. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R, Baudier J, Saitoh T (1992) Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease. Brain Res 574: 312-316
26. Masliah M, Mallory M, Hansen L, DeTeresa R, Alford M, Terry R (1994) Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 174: 67-72
27. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydell RE (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the betaamyloid precursor protein. Neuron 10: 243-254
28. Morrison LD, Bergeron C, Kish SJ (1993) Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease. Neurosci Lett 154: 141-144
29. Mucke L, Abraham CR, Masliah E (1996) Neurotrophic and neuroprotective effects of hAPP in transgenic mice. Ann NY Acad Sci 777: 82-88
30. Neve RL, Rogers J, Higgins GA (1990) The Alzheimer amyloid precursor-related transcript lacking the beta/A4 sequence is specially increased in Alzheimer's disease brains. Neuron 5: 329-338
31. Oltersdorf T, Ward PJ, Henriksson T, Beattie EC, Neve R, Liederburg I, Fritz LC (1990) The Alzheimer amyloid precursor protein. J Biol Chem 265: 4492-497
32. Palmert MR, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, Usiak MF, Younkin LH, Younkin SG (1988) Amyloid protein precursor messenger RNAs - differential expression in Alzheimer disease. Science 241: 1080-1084
33. Petralia RS, Wang YX, Wenthold RJ (1994) The NMDA-receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J Neurosci 14: 6102-6120
34. Puchalski RB, Louis JC, Brose N, Traynelis SF, Egbjerg J, Kukekov V, Wenthold RJ, Rogers SW, Lin F, Moran T, Morrison JH, Stephen FH (1994) Selective RNA editing and subunit assembly of native glutamate receptors. Neuron 13: 131- 147
35. Quon D, Catalano R, Cordell B (1990) Fibroblast growth factor induces β-amyloid precursor mRNA in glial but not neuronal culture cells. Biochem Biophys Res Commun 167: 96-102
36. Roberts GW, Nash M, Ince PG, Royston MC, Gentleman SM (1993) On the origin of Alzheimer's disease: a hypothesis. NeuroReport 4: 7-9
37. Roch J-M, Masliah E, Roch-Levecq A-C, Sundsmo MP, Otero DAC, Veinbergs I, Saitoh T (1994) Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc Natl Acad Sci USA 91: 7450-7454
38. Rockenstein EM, McConlogue L, Tan H, Power M, Masliah E, Mucke L (1995) Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem 270: 28257-28267
39. Samuel W, Galasko D, Masliah E, Hansen LA (1996) Neurocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. Neuropathol Exp Neurol 55: 44-52
40. Schubert D, Jin LW, Saitoh T, Cole G (1989) The regulation of amyloid b protein precursor and its modulatory role in cell adhesion. Neuron 3: 689-694
41. Solodkin A, Hoesen GW van (1996) Entorhinal cortex modules of the human brain. J Comp Neurol 365: 610-627
42. Tanzi RE, Wenniger JJ, Hyman BT (1993) Cellular specificity and regional distribution of amyloid beta protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation. Mol Brain Res 18: 246-252
43. Valerien A, Alberici A, Paterlini M, Grilli M, Galli P, Pizzi M, Memo M, Spano P (1995) Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. NeuroReport 6: 1317-1321
44. Wakabayashi K, Honer WG, Masliah E (1994) Synapse alterations in the hippocampal-entorhinal formation in Alzheimers disease with and without Lewy body disease. Brain Res 667: 24-32
45. West MJ, Coleman PD, Flood DC, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease. Lancet 344: 769-772
46. Whetsell WO (1996) Current concepts of excitotoxicity. J Neuropathol Exp Neurol 55: 1-13
47. Yasuda RP, Ikonomovic MD, Sheffield R, Rubin RT, Wolfe BB, Armstrong DM (1995) Reduction of AMPA-selective glutamate receptor subunits in the EC of patients with Alzheimer's disease pathology: a biochemical study. Brain Res 678: 161- 167